
Aviv Regev
Articles
-
2 months ago |
nature.com | Methodios Ximerakis |Richard M. Giadone |Samara Santiago |Kavya Shah |Aviv Regev |Joshua Levin
Correction to: Nature Aging https://doi.org/10.1038/s43587-023-00373-6, published online 9 March 2023. Following publication, the authors were alerted to a potential duplication in two of the micrographs shown in the paper. After a detailed review, it appears that two probes (Hspa1a and Pecam1) in an RNA in situ hybridization experiment were unintentionally swapped in the representative images shown in Figs. 5c and 8b of the published manuscript.
-
Jan 14, 2025 |
biorxiv.org | Sarah Chen |Aviv Regev |Anne Condon |Jiarui Ding
AbstractSingle-cell RNA-seq data have provided new insights into intracellular and intercellular processes. Because multiple processes are active in each cell simultaneously, such as its cell type program, differentiation, the cell cycle, and environmental responses, their respective signals can confound one another, requiring methods that can separate and filter different complex biological signals.
-
Dec 5, 2024 |
nature.com | Hojun Li |Katie Frenis |Mayuri Tanaka-Yano |Giuseppe Tarantino |Vincent L. Butty |Marcelo Falchetti | +7 more
AbstractOver a lifetime, hematopoietic stem cells (HSCs) adjust their lineage output to support age-aligned physiology. In model organisms, stereotypic waves of hematopoiesis have been observed corresponding to defined age-biased HSC hallmarks. However, how the properties of hematopoietic stem and progenitor cells change over the human lifespan remains unclear.
-
Nov 11, 2024 |
nature.com | Carman Man-Chung Li |Francesca Silvestri |Nomeda Girnius |Aviv Regev |Alyssa Cordes |S. Cigall Kadoch
AbstractGermline BRCA1 mutation carriers face a high breast cancer risk; however, the underlying mechanisms for this risk are not completely understood. Using a new genetically engineered mouse model of germline Brca1 heterozygosity, we demonstrate that early tumor onset in a Brca1 heterozygous background cannot be fully explained by the conventional ‘two-hit’ hypothesis, suggesting the existence of inherent tumor-promoting alterations in the Brca1 heterozygous state.
-
Oct 16, 2024 |
nature.com | Martin W. LaFleur |Rocky M. Barilla |Ayshwarya Subramanian |Yoon-Chul Kye |John G. Doench |Isaac M. Chiu | +2 more
AbstractThe balance between T helper type 1 (TH1) cells and other TH cells is critical for antiviral and anti-tumour responses1,2,3, but how this balance is achieved remains poorly understood. Here we dissected the dynamic regulation of TH1 cell differentiation during in vitro polarization, and during in vivo differentiation after acute viral infection.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →